Carasent AB (publ) (STO:CARA)
Sweden · Delayed Price · Currency is SEK 22.85
+0.15 (0.66%)
Mar 25, 2026, 3:02 PM CET
Carasent AB Market Cap
Carasent AB has a market cap or net worth of 1.55 billion as of March 25, 2026. Its market cap has decreased by -1.87% in one year.
Market Cap
1.55B
Enterprise Value
1.45B
Revenue
343.82M
Ranking
n/a
PE Ratio
45.40
Stock Price
22.85
Market Cap Chart
Since December 12, 2012, Carasent AB's market cap has increased from 48.86M to 1.55B, an increase of 3,081.13%. That is a compound annual growth rate of 29.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 1.55B | -19.04% |
| Dec 30, 2025 | 1.92B | 19.57% |
| Dec 30, 2024 | 1.61B | 3,186.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 124.44B |
| Getinge AB | 49.58B |
| Sectra AB | 42.43B |
| Medicover AB | 27.78B |
| Egetis Therapeutics AB | 1.96B |
| Cereno Scientific AB | 1.95B |
| Stille AB | 1.77B |
| Surgical Science Sweden AB | 1.56B |